NexImmune, Inc. — Form D
NexImmune, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-22. The offering totals $10.0M, of which $7.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-22
- Form: D
- Accession: 0001538210-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $7.8M
- Remaining: $2.2M
- Investors: 42
- Date of first sale: 2019-01-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333353
Issuer
- Name: NexImmune, Inc.
- CIK: 0001538210
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 9119 Gaither Road, GAITHERSBURG, MD, 20877
- Phone: 301-825-9810
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Timothy Bertram | Director | Winston-Salem, NC |
| Scott Carmer | Director | Gaithersburg, MD |
| Paul D'Angio | Director | Gaithersburg, MD |
| Alan Roemer | Director | Gaithersburg, MD |
| Robert Spiegel | Director | Berkeley Heights, NJ |
| Bing Yao | Director | Gaithersburg, MD |
| Tony Yao | Director | Denver, CO |
| Alain Cappeluti | Executive Officer | Gaithersburg, MD |
| Scott Carmer | Executive Officer | Gaithersburg, MD |
| James Barrett | Director | Richmond, VA |
| Kenneth Carter | Director | SAN FRANCISCO, CA |
| Kenneth Carter | Executive Officer | SAN FRANCISCO, CA |
| Alain Cappeluti | Director | Gaithersburg, MD |
| Janis Naeve | Director | Gaithersburg, MD |
| Jonathan Schneck | Director | Gaithersburg, MD |
| Slain Cappeluti | Director | Gaithersburg, MD |
| Slain Cappeluti | Executive Officer | Gaithersburg, MD |
Other filings by this issuer (6)
More